Cryoport, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cryoport, Inc. on February 24, 2012, covering events occurring on February 17, 2012. The filing details the entry into a material definitive agreement for a private placement of securities and the subsequent sale of unregistered securities.
Key Financial Metrics and Transaction Details
- Total Units Sold: 9,484,009 units (comprising common stock and warrants).
- Purchase Price: $0.55 per unit.
- Aggregate Gross Proceeds: $5,216,205.
- Initial Closing Proceeds (Feb 22, 2012): $3,737,565 released from escrow.
- Remaining Proceeds: $1,478,640 expected by March 2, 2012.
- Warrant Terms: Exercise price of $0.69 per share; five-year term; immediately exercisable.
- Placement Agent Fees: $450,601 in commissions, $43,530 in expense reimbursements, and 248,633 warrants.
- Use of Proceeds: Working capital purposes.
Material Changes and Related Agreements
The Company executed a definitive securities purchase agreement with institutional and accredited investors. To facilitate this transaction, the Company obtained a waiver from holders of outstanding convertible debentures to prevent defaults triggered by the new issuance. In consideration for this waiver, the Company issued 280,000 additional warrants to the debenture holders at an exercise price of $0.69 per share.
The Company is obligated to file a registration statement for the resale of shares within 30 days of the transaction close. If the SEC does not declare the statement effective within specified timeframes (60 or 90 days depending on review status), the Company must make monthly payments equal to 2% or 3% of the initial investment in cash or stock.
Guidance, Risks, and Contingencies
The filing does not provide specific financial guidance or outlook beyond the stated intent to use proceeds for working capital. Key contingencies include:
- Registration Risk: Potential obligation to make penalty payments if the resale registration statement is not declared effective within the mandated periods.
- Liquidity Timing: A portion of the gross proceeds ($1.48 million) remains in escrow pending release by March 2, 2012.
Investor Verification Checklist
- Verify the release date and amount of the remaining $1,478,640 in escrowed proceeds.
- Confirm the filing date and status of the registration statement for the resale of shares.
- Review the full text of the Securities Purchase Agreement (Exhibit 4.16) and Registration Rights Agreement (Exhibit 4.17) for detailed penalty clauses regarding registration delays.
- Assess the dilution impact of the 9,484,009 new shares and the associated warrants (including those issued to debenture holders and placement agents).